MIR548AY

Across TCGA pan-cancer cohorts, MIR548AY RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR548AY’s most consistent transcriptional readouts.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where MIR548AY RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR548AY is over-expressed in tumor, although a few such as LUSC show the opposite, repressed pattern.

LIHC, LUSC, and LUAD are the cancer types where MIR548AY tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR548AY RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LIHC	All	II,III,IV	+0.171	.030	4	view →
LUSC	Female	III,IV	−0.730	.001	2	view →
LUAD	Male	II,III,IV	+0.293	.040	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

MIR548AY–LIHC

Open the LIHC breakdown →